Blood-brain barrier permeability for ammonia in patients with different grades of liver fibrosis is not different from healthy controls
- PMID: 20216550
- PMCID: PMC2949228
- DOI: 10.1038/jcbfm.2010.22
Blood-brain barrier permeability for ammonia in patients with different grades of liver fibrosis is not different from healthy controls
Abstract
Increased blood-brain barrier (BBB) permeability for ammonia is considered to be an integral part of the pathophysiology of hepatic encephalopathy (HE) in patients with liver cirrhosis. Increased glutamate-/glutamine-signal intensity in magnetic resonance spectroscopic studies of the brain in cirrhotic patients was explained as a consequence of increased cerebral ammonia uptake. As similar spectroscopic alterations are present in patients with liver fibrosis, we hypothesized that BBB permeability for ammonia is already increased in liver fibrosis, and thereby contributing to the development of HE. To test this hypothesis, cerebral perfusion and ammonia metabolism were examined through positron emission tomography with (15)O-water, respectively, (13)N-ammonia in patients with Ishak grades 2 and 4 fibrosis, cirrhosis, and healthy controls. There were neither global nor regional differences of cerebral blood flow, the rate constant of unidirectional transport of ammonia from blood into brain tissue, the permeability surface area product of the BBB for ammonia, the net metabolic clearance rate constant of ammonia from blood into glutamine in brain, or the metabolic rate of ammonia. The hypothesis that increased permeability of the BBB for ammonia in patients with liver fibrosis contributes to the later development of HE could not be supported by this study.
Figures




Similar articles
-
Brain metabolism of 13N-ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography.Hepatology. 2006 Jan;43(1):42-50. doi: 10.1002/hep.21001. Hepatology. 2006. PMID: 16374868
-
Brain metabolism in patients with hepatic encephalopathy studied by PET and MR.Arch Biochem Biophys. 2013 Aug 15;536(2):131-42. doi: 10.1016/j.abb.2013.05.006. Epub 2013 May 30. Arch Biochem Biophys. 2013. PMID: 23726863 Review.
-
Regional differences in cerebral blood flow and cerebral ammonia metabolism in patients with cirrhosis.Hepatology. 2004 Jul;40(1):73-9. doi: 10.1002/hep.20290. Hepatology. 2004. PMID: 15239088
-
Correlations between magnetic resonance spectroscopy alterations and cerebral ammonia and glucose metabolism in cirrhotic patients with and without hepatic encephalopathy.Gut. 2007 Dec;56(12):1736-42. doi: 10.1136/gut.2006.110569. Epub 2007 Jul 27. Gut. 2007. PMID: 17660226 Free PMC article.
-
New findings on cerebral ammonia uptake in HE using functional (13)N-ammonia PET.Metab Brain Dis. 2007 Dec;22(3-4):277-84. doi: 10.1007/s11011-007-9066-1. Metab Brain Dis. 2007. PMID: 17828586 Review.
Cited by
-
Hepatic encephalopathy: An approach to its multiple pathophysiological features.World J Hepatol. 2012 Mar 27;4(3):50-65. doi: 10.4254/wjh.v4.i3.50. World J Hepatol. 2012. PMID: 22489256 Free PMC article.
-
Update on cerebral uptake of blood ammonia.Metab Brain Dis. 2013 Jun;28(2):155-9. doi: 10.1007/s11011-013-9395-1. Epub 2013 Mar 13. Metab Brain Dis. 2013. PMID: 23479402 Review.
-
Hepatic Encephalopathy and Melatonin.Antioxidants (Basel). 2022 Apr 25;11(5):837. doi: 10.3390/antiox11050837. Antioxidants (Basel). 2022. PMID: 35624703 Free PMC article. Review.
-
The Metabolic Impact of Nonalcoholic Fatty Liver Disease on Cognitive Dysfunction: A Comprehensive Clinical and Pathophysiological Review.Int J Mol Sci. 2024 Mar 15;25(6):3337. doi: 10.3390/ijms25063337. Int J Mol Sci. 2024. PMID: 38542310 Free PMC article. Review.
-
Evaluation of [13N]ammonia positron emission tomography as a potential method for quantifying glutamine synthetase activity in the human brain.EJNMMI Res. 2020 Dec 3;10(1):146. doi: 10.1186/s13550-020-00731-0. EJNMMI Res. 2020. PMID: 33270177 Free PMC article.
References
-
- Ahl B, Weissenborn K, van den Hoff J, Fischer-Wasels D, Köstler H, Hecker H, Burchert W. Regional differences in cerebral blood flow and cerebral ammonia metabolism in patients with cirrhosis. Hepatology. 2004;40:73–79. - PubMed
-
- Andersson JLR, Vagnhammar BE, Schneider H. Accurate attenuation correction despite movement during PET imaging. J Nucl Med. 1995;36:670–678. - PubMed
-
- Berding G, Banati RB, Buchert R, Chierichetti F, Grover VPB, Kato A, Keiding S, Taylor-Robinson SD. Radiotracer imaging studies in hepatic encephalopathy: ISHEN practice guidelines. Liver Int. 2009;29:621–628. - PubMed
-
- Butterworth RF. Pathogenesis of hepatic encephalopathy: new insights from neuroimaging and molecular studies. J Hepatol. 2003;39:278–285. - PubMed
-
- Carroll TJ, Teneggi V, Jobin M, Squassante L, Treyer V, Hany TF, Burger C, Wang L, Bye A, von Schulthess GK, Buck A. Absolute quantification of cerebral blood flow with magnetic resonance, reproducibility of the method, and comparison with H2(15)O positron emission tomography. J Cereb Blood Flow Metab. 2002;22:1149–1156. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials